EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Win Ratio Aligns With and Enhances Interpretation of REPRIEVE's Primary Findings

Emma Davies Smith iD, Pamela S Douglas iD, Sara McCallum iD, James Troendle iD, Marissa R Diggs, Alex B Lu, Sarah M Chu, Triin Umbleja iD, Michael T Lu, Markella V Zanni, Steven K Grinspoon iD, Heather J Ribaudo iD

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciaf477 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Emma Davies Smith und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Quinolines, HIV Infections, Cardiovascular Diseases, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We performed a win ratio (WR) analysis of REPRIEVE, a randomized trial of pitavastatin vs placebo for cardiovascular disease in people with human immunodeficiency virus to assess robustness to event severity. WR aligns with primary findings and provides insight into pitavastatin protections: persistent advantage on death, stroke, and myocardial infarction. Clinical Trials Registration . NCT02344290.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinolinesHIV InfectionsCardiovascular DiseasesHydroxymethylglutaryl-CoA Reductase InhibitorsHumansMyocardial InfarctionStrokeMaleFemaleRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

REPRIEVEcomposite outcomeshazard ratiotime-to-first-event analysiswin ratio

Substanzen

QuinolinespitavastatinHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Office of Biostatistics Research, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
  • Cardiovascular Imaging Research Center, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Emma Davies Smith, Pamela S Douglas, Sara McCallum, James Troendle, Triin Umbleja, Steven K Grinspoon, Heather J Ribaudo

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Davies Smith, E., Douglas, P. S., McCallum, S., Troendle, J., Diggs, M. R., Lu, A. B., Chu, S. M., Umbleja, T., Lu, M. T., Zanni, M. V., Grinspoon, S. K., & Ribaudo, H. J. (2026). Win Ratio Aligns With and Enhances Interpretation of REPRIEVE's Primary Findings. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf477

Vancouver

Davies Smith E, Douglas PS, McCallum S, Troendle J, Diggs MR, Lu AB, et al. Win Ratio Aligns With and Enhances Interpretation of REPRIEVE's Primary Findings. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf477

BibTeX
@article{DaviesSmith2026,
  author = {Davies Smith, Emma and Douglas, Pamela S and McCallum, Sara and Troendle, James and Diggs, Marissa R and Lu, Alex B and Chu, Sarah M and Umbleja, Triin and Lu, Michael T and Zanni, Markella V and Grinspoon, Steven K and Ribaudo, Heather J},
  title = {Win Ratio Aligns With and Enhances Interpretation of REPRIEVE's Primary Findings},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciaf477}
}
Kostenlos starten →